43 results
8-K
EX-99.1
AIMD
Ainos Inc
13 May 24
Ainos Reports First Quarter 2024 Financial Results
4:10pm
Nose technology platform-powered POCT candidate, Ainos Flora, and co-develop an innovative volatile organic compounds (“VOC”) sensing platform … , automotive, industrial, and environmental safety. Our first project aims to improve the quality of elderly care through an innovative AI-driven telehealth
8-K
EX-99.1
AIMD
Ainos Inc
11 Aug 23
Ainos Reports Second Quarter 2023 Financial Results
5:30pm
VOC POCT device, which utilizes our innovative AI Nose technology to quickly and discreetly test for vaginal infection and certain common STIs. Ainos … . is a diversified healthcare company engaged in developing innovative medical technologies for point-of-care testing and safe and novel medical treatment
8-K
EX-99.1
AIMD
Ainos Inc
9 Aug 23
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
9:30pm
. To achieve this vision, the Parties have committed to collaborating on the development of innovative technologies by leveraging Ainos' cutting-edge … .
About Ainos, Inc.
Headquartered in San Diego, California, Ainos, Inc. is a diversified healthcare company engaged in developing innovative medical
8-K
EX-99.1
AIMD
Ainos Inc
18 May 23
Ainos Appoints Amanda Sung as New Chief Financial Officer
5:05pm
engaged in developing innovative medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease
NT 10-K
EX-99
AIMD
Ainos Inc
31 Mar 23
Notice of late annual filing
9:45pm
of further out-licensing opportunities for our VELDONA® candidates. Going forward, we will continue to advance and develop our innovative technologies while … Ainos, Inc.
Headquartered in San Diego, California, Ainos, Inc. is a diversified medtech company engaged in developing innovative medical technologies
8-K
EX-99.1
8ozgaxrfp1rl ognfb3
16 Aug 22
Ainos Reports Second Quarter 2022 Financial Results
7:22am
8-K
EX-99.1
aggizmug9l084u6zm
12 Aug 22
Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split
4:12pm
8-K
EX-99.2
gbsnq
12 Aug 22
Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split
4:12pm
8-K
EX-99.1
fvxz1l0cl2fou xp
8 Dec 21
Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection
2:44pm
DEF 14C
pilxmr
19 Mar 21
Information statement
12:00am
PRE 14C
v3bonmb2z2qge c0
28 Jan 21
Preliminary information
9:54am
8-K
EX-99.1
9ys xhpuxe
30 Dec 20
Amarillo Biosciences, Inc. Enters into a Securities Purchase Agreement to Foster New Growth
3:21pm